Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Carcinoma × osimertinib × Clear all

Phase

Status

Active not recruiting 3 Terminated 2 Recruiting 2 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Carcinoma, Non-Small-Cell Lung 30 Lung Neoplasms 10 Neoplasms 5 Neoplasm Metastasis 4 Thoracic Neoplasms 2 Noonan Syndrome 2 NSCLC 2 Meningeal Carcinomatosis 2 Colorectal Neoplasms 2 Brain Neoplasms 2 Adenocarcinoma of Lung 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 T790M Positive NSCLC Patients 1 Solid Tumor 1 Skin Neoplasms 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Progression Free Survival 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Non Small Cell Lung Cancer Metastatic 1 Neoplasms, Squamous Cell 1 Neoplasms by Site 1 Lung Diseases 1 Locally Advanced or Metastatic EGFR T790M+ NSCLC 1 Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer 1 Inhibition, Psychological 1 Glioblastoma 1

Interventions

Carboplatin 24 Paclitaxel 21 Gemcitabine 17 Cisplatin 16 pembrolizumab 12 Everolimus 8 Docetaxel 8 Radiotherapy, Intensity-Modulated 7 Pemetrexed 7 Fluorouracil 7 130-nm albumin-bound paclitaxel 7 Radiotherapy 6 Nivolumab 6 Cetuximab 6 Panitumumab 5 Cyclophosphamide 5 Bevacizumab 5 Axitinib 5 trebananib 4 lenvatinib 4 Sunitinib 4 Sorafenib 4 Irinotecan 4 Gefitinib 4 volociximab 3 reolysin 3 padeliporfin 3 epothilone B 3 durvalumab 3 Octreotide 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02529995 2020-02-11

AURAChinaPK

AstraZeneca

Phase 1 Completed

31 enrolled 22 charts

Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡